Anavex Life Sciences
AVXL
#8577
Rank
NZ$0.42 B
Marketcap
NZ$4.56
Share price
1.57%
Change (1 day)
-70.53%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.93

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.95. a decrease over its 2024 EPS that were of NZ-$0.92.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.953.85%
2024NZ-$0.92-13.33%
2023NZ-$1.06-3.23%
2022NZ-$1.1014.81%
2021NZ-$0.9520%
2020NZ-$0.80-16.67%
2019NZ-$0.9538.46%
2018NZ-$0.6918.18%
2017NZ-$0.58-21.43%
2016NZ-$0.74-35.38%
2015NZ-$1.15-36.27%
2014NZ-$1.80112.5%
2013NZ-$0.85-58.62%
2012NZ-$2.05-0%
2011NZ-$2.05-29.27%
2010NZ-$2.9051.85%
2009NZ-$1.91-0%
2008NZ-$1.91237.5%
2007NZ-$0.57
2006N/A-100%
2005NZ-$0.07069499.97%
2004NZ-$0.01178

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$11.13-1,266.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.80-183.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$52.84 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$2.21-331.48%๐Ÿ‡บ๐Ÿ‡ธ USA